AI Can Help Spot Congenital Heart Defects

Follow Drugslib on

Medically reviewed by Drugs.com.

By Dennis Thompson HealthDay Reporter

FRIDAY, Jan. 31, 2025 -- Artificial intelligence (AI) can help doctors detect fetal heart defects, improving newborns’ chances of survival, a new study says.

AI-aided analysis of prenatal ultrasounds detected heart defects more quickly and accurately than doctors evaluating the tests on their own, according to findings reported Thursday at a meeting of the Society for Maternal-Fetal Medicine in Denver.

“AI-based software significantly improved detection of ultrasounds that were suspicious for congenital heart defects not only among OB-GYNs but also among maternal-fetal medicine subspecialists,” said lead researcher Dr. Jennifer Lam-Rachlin, director of fetal echocardiography at Carnegie Imaging for Women at Mount Sinai West in New York City.

“This has a tremendous impact in terms of neonatal outcomes and has the potential to change clinical practice,” she added in a news release.

About 1 in 4 babies born with a heart defect has one serious enough to require surgery or other medical treatment within the first year of life, researchers said in background notes.

Prenatal ultrasounds can provide an important early warning for such heart defects, but these crucial scans often are analyzed by doctors without extensive training.

“At least half of prenatal ultrasounds in the United States are being looked at by non-specialists, medical professionals — including OB-GYNs — who may not be trained in prenatal ultrasound,” Lam-Rachlin said. “That accounts for why the ability to detect congenital heart defects is still quite low, even in developed countries like the U.S.”

For this study, a group of 14 OB-GYNs and maternal-fetal medicine specialists randomly reviewed 200 prenatal ultrasounds gathered from 11 hospitals in two countries. The doctors ranged in experience from one year on the job to more than three decades.

Sometimes the doctors were assisted by AI in their analysis of the ultrasounds, and sometimes not, researchers said.

Results showed that the AI system significantly improved doctors’ ability to detect cases suspicious for congenital heart defects.

AI boosted the doctors' evaluations regardless of their years of experience or training in the maternal-fetal specialty, researchers said.

Doctors also became more confident in detecting heart defects when aided by AI, and it took them less time to determine whether a case was suspicious or not.

“Most congenital heart defects occur in pregnancies that are considered low risk, which means the pregnant person is most likely being seen by an OB-GYN versus a maternal-fetal medicine subspecialist who has more experience in detecting congenital heart defects,” researcher Christophe Gardella, chief technical officer for BrightHeart, the Paris-based manufacturer of the AI-based software, said in a news release.

BrightHeart received U.S. Food and Drug Administration (FDA) approval for its AI software in November, and is preparing to launch it commercially in the U.S.

“Fetal heart assessments are among the most technically demanding aspects of prenatal ultrasound,” Cécile Dupont, BrightHeart CEO, said in a news release at the time of the FDA approval. “Our AI-powered solution not only assists clinicians in detecting signs of potential abnormalities earlier but also enhances their confidence in confirming normal findings, which is equally critical for the peace of mind of expectant families.”

Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.

Sources

  • Society for Maternal-Fetal Medicine, news release, Jan. 30, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-02-01 00:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords